Product Description |
Recombinant Human AGER Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Ala23- Ala344. |
Product Background |
The receptor for advanced glycation end products (AGER) is an oncogenic transmembranous receptor up-regulated in various human cancers. AGER promotes proliferation, migration, and inhibits apoptosis of squamous cervical cancer and might function as a tumor promoter in cervical cancer. Our study provides novel evidence for a potential role of AGER in bridging human papillomavirus (HPV)-induced inflammation and cervical cancer. |
Product Category |
Recombinant Protein |
Target |
AGER |
Synonyms |
AGER; RAGE; SCARJ1 |
Accession |
|
Species |
Human |
Biotinylated |
no |
Amino Acid Range |
Ala23- Ala344 |
Molecular Weight |
The protein has a predicted MW of 35.3 kDa. Due to glycosylation, the protein migrates to 50-60 kDa based on Bis-Tris PAGE result. |
Product Tag |
C-His |
Express System |
HEK293 |
Purity |
> 95% as determined by Bis-Tris PAGE;> 95% as determined by HPLC |
Endotoxin |
Less than 1EU per ug by the LAL method. |
Form |
Lyophilized |
Shipping |
Shipped at ambient temperature. |
Formulation |
Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Reconstitution |
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
Stability And Storage |
Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
|
Human AGER on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. |
|
|
The purity of Human AGER is greater than 95% as determined by SEC-HPLC. |
Related Products
Recently viewed
